Introduction
Extramammary Paget's disease (EMPD) is a rare skin malignant tumor that shows erythematous plaques and erosions in pubic or axillary lesions. Although the prognosis of EMPD with distant metastasis is poor, an effective therapy has not yet established. Thus, there is need to investigate molecular targets for EMPD.
Recently, EpCAM (epithelial cell adhesion molecule, CD326) has attracted attention as both prognostic marker and therapeutic target in several cancers (1) . EpCAM is involved in not only cell adhesion but also cellular signaling, cell migration, proliferation and differentiation (2) . EpCAM is overexpressed in many malignant tumors, e.g. prostatic, ovarian, urothelial and breast carcinoma (2) . The anti-EpCAM antibody (catumaxomab) has been authorized for treatment of malignant ascites in cancer patients (3) . On the other hand, EpCAM has been reported to be a tumor suppressive protein in certain types of cancers such as oral, rectal and endometrial carcinoma (4-6) although the molecular mechanism of the tumor suppressive function of EpCAM in several cancers has not been found yet (7) . Moreover, EpCAM is an important surface marker of circulating tumor cell (CTC) (8) , and the CellSearch system (CTC detector of circulating EpCAM +
CD45
-cells) is approved by FDA (9). Thus, the purpose of our study was to examine the expression levels of EpCAM and evaluate the correlation between its intensity of EpCAM and the clinical characteristics of EMPD. 
Materials and Methods

Patients
Immunohistochemical staining
Paraffin-embedded sections were mounted on glass slides, then dewaxed in Clear Plus (FALMA, Japan) and rehydrated in graded alcohols. Immunohistochemistry (IHC) antigen activation was performed by incubation with antigen retrieval solution (pH9, Nichirei, Japan) for 10 min at 121℃. The sections were then incubated overnight with the antibody against EpCAM (Dako, CA, USA, 1:50) at 4℃. The immunoreactivity was visualized with DAB. We used the following grading system: -negative staining, + for slight staining, ++ for strong staining, as described previously (10).
Statistical analysis
Correlations were assessed according to Fisher's correlation coefficient and its statistical analyses were performed using GraphPad Prism version 7 (MDF, Tokyo, Japan). A p value less than 0.05 was considered significant.
Results and Discussion
First, we investigated EpCAM protein expression in EMPD using immunohistochemical staining. Immunohistochemistry of EpCAM revealed that EMPD cells had more intense staining than the normal keratinocytes cells in same tissue samples (Figure 1 (Figure 1 and Table 1 ). The expression of EpCAM in EMPD patients with distant metastasis was significantly decreased compared to that in patients without distant metastasis (p = 0.036), although it did not correlate any other clinical findings (age: p = 0.365, sex: p = 0.087, the degree of invasiveness: p = 0.826, the presence of lymph node metastasis: p = 0.132) ( Table 2) .
In this study, we presented two novel findings: first, we found that almost all EMPD tissues were positive for EpCAM. Furthermore, the staining intensity of EpCAM protein negatively correlated with the presence of distant metastasis. EpCAM is overexpressed in several cancers such as adenocarcinomas of colon, stomach, pancreas and lung (11) (12) (13) . As with these cancers, our results showed that almost all EMPD tissues were positive for EpCAM. It suggests that EpCAM may be a novel therapeutic target in EMPD.
Overexpression of EpCAM was associated with an advanced stage of the disease and linked to worse overall survival in certain tumor types (2) . On the other hand, EpCAM could be a tumor suppressive protein in certain types of cancers (7) . In gastric cancer, EpCAM appeared to be associated with a more favorable prognosis (14) . Besides, the loss of EpCAM in rectal cancer was associated with the reduction of cell-cell adhesion and the augmentation of migration function (15) . Our results showed that the EpCAM expression negatively correlated with the presence of distant metastasis. Taken together, these findings suggest that Moreover, EpCAM is an important surface marker of CTC (8) . Overexpression of EpCAM in EMPD cells may facilitate the research of CTC in EMPD. Based on Case   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32   Age   85  78  77  76  81  66  76  68  71  72  69  69  71  78  87  63  82  67  78  76  78  74  64  54  64  65  60  76  90  59  83  94   Sex   Male  Male  Male  Female  Male  Male  Female  Male  Female  Male  Male  Male  Female  Male  Female  Female  Male  Female  Female  Male  Male  Male  Female  Male  Male  Female  Male  Female  Female  Female  Male  Female   The degree Table 2 . Correlation between the semiquantitative e v a l u a t i o n o f t h e E p C A M p ro t e i n a n d p a t i e n t characteristics 
